AAAAAA

   
Results: 1-25 | 26-50 | 51-52
Results: 26-50/52
ACUTE PACING STUDIES ARE NOT VALUABLE IN PREDICTING LONG-TERM BENEFITS OF DDD PACING FOR LV OUTFLOW OBSTRUCTION N HYPERTROPHIC CARDIOMYOPATHY
Authors: MCAREAVEY D FANANAPAZIR L
Citation: D. Mcareavey et L. Fananapazir, ACUTE PACING STUDIES ARE NOT VALUABLE IN PREDICTING LONG-TERM BENEFITS OF DDD PACING FOR LV OUTFLOW OBSTRUCTION N HYPERTROPHIC CARDIOMYOPATHY, Journal of the American College of Cardiology, 1994, pp. 10000010-10000010
DUAL-CHAMBER PACING IS EFFECTIVE THERAPY FOR HYPERTROPHIC CARDIOMYOPATHY PATIENTS WITH PROVOCABLE LV OUTFLOW TRACT OBSTRUCTION AND SYMPTOMSREFRACTORY TO MEDICAL THERAPY
Authors: MCAREAVEY D EPSTEIN ND FANANAPAZIR L
Citation: D. Mcareavey et al., DUAL-CHAMBER PACING IS EFFECTIVE THERAPY FOR HYPERTROPHIC CARDIOMYOPATHY PATIENTS WITH PROVOCABLE LV OUTFLOW TRACT OBSTRUCTION AND SYMPTOMSREFRACTORY TO MEDICAL THERAPY, Journal of the American College of Cardiology, 1994, pp. 10000011-10000011
SAFETY OF DEFIBRILLATOR IMPLANTATION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
Authors: ODONOGHUE S PLATIA E MISPIRETA L BOYCE S PANZA J TRIPODI D MCAREAVEY D FANANAPAZIR L
Citation: S. Odonoghue et al., SAFETY OF DEFIBRILLATOR IMPLANTATION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY, Journal of the American College of Cardiology, 1994, pp. 10000011-10000011
RISK STRATIFICATION OF ASYMPTOMATIC PATIENTS WITH HYPERTROPIC CARDIOMYOPATHY
Authors: ATIGA WL MCAREAVEY D EPSTEIN ND FANANAPAZIR L
Citation: Wl. Atiga et al., RISK STRATIFICATION OF ASYMPTOMATIC PATIENTS WITH HYPERTROPIC CARDIOMYOPATHY, Journal of the American College of Cardiology, 1994, pp. 130000110-130000110
RADIOFREQUENCY CATHETER ATRIOVENTRICULAR NODE ABLATION IN PATIENTS WITH PERMANENT CARDIAC PACING SYSTEMS
Authors: CHANG AC MCAREAVEY D TRIPODI D FANANAPAZIR L
Citation: Ac. Chang et al., RADIOFREQUENCY CATHETER ATRIOVENTRICULAR NODE ABLATION IN PATIENTS WITH PERMANENT CARDIAC PACING SYSTEMS, PACE, 17(1), 1994, pp. 65-69
ABNORMAL FUNCTION OF BETA-MYOSIN IN HYPERTROPHIC CARDIOMYOPATHY
Authors: CUDA G FANANAPAZIR L EPSTEIN ND SELLERS JR
Citation: G. Cuda et al., ABNORMAL FUNCTION OF BETA-MYOSIN IN HYPERTROPHIC CARDIOMYOPATHY, Journal of muscle research and cell motility, 15(2), 1994, pp. 206-206
LONG-TERM RESULTS OF DUAL-CHAMBER (DDD) PACING IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY - EVIDENCE FOR PROGRESSIVE SYMPTOMATIC AND HEMODYNAMIC IMPROVEMENT AND REDUCTION OF LEFT-VENTRICULAR HYPERTROPHY
Authors: FANANAPAZIR L EPSTEIN ND CURIEL RV PANZA JA TRIPODI D MCAREAVEY D
Citation: L. Fananapazir et al., LONG-TERM RESULTS OF DUAL-CHAMBER (DDD) PACING IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY - EVIDENCE FOR PROGRESSIVE SYMPTOMATIC AND HEMODYNAMIC IMPROVEMENT AND REDUCTION OF LEFT-VENTRICULAR HYPERTROPHY, Circulation, 90(6), 1994, pp. 2731-2742
FAILURE OF DDD PACING TO RELIEVE SYMPTOMS AND LV OUTFLOW OBSTRUCTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY - INCIDENCE, MECHANISMS AND MANAGEMENT
Authors: ATIGA WL MCAREAVEY D FANANAPAZIR L
Citation: Wl. Atiga et al., FAILURE OF DDD PACING TO RELIEVE SYMPTOMS AND LV OUTFLOW OBSTRUCTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY - INCIDENCE, MECHANISMS AND MANAGEMENT, Circulation, 90(4), 1994, pp. 171-171
FAILURE OF DDD PACING TO RELIEVE SYMPTOMS AND LV OUTFLOW OBSTRUCTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY - INCIDENCE, MECHANISMS AND MANAGEMENT
Authors: ATIGA WL MCAREAVEY D FANANAPAZIR L
Citation: Wl. Atiga et al., FAILURE OF DDD PACING TO RELIEVE SYMPTOMS AND LV OUTFLOW OBSTRUCTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY - INCIDENCE, MECHANISMS AND MANAGEMENT, Circulation, 90(4), 1994, pp. 171-171
IDENTIFICATION OF BETA-MYOSIN HEAVY-CHAIN GENE-MUTATIONS IN 31 ATHLETES WITH HYPERTROPHIC CARDIOMYOPATHY
Authors: FANANAPAZIR L WINKLER JB SATORIUS C EPSTEIN ND
Citation: L. Fananapazir et al., IDENTIFICATION OF BETA-MYOSIN HEAVY-CHAIN GENE-MUTATIONS IN 31 ATHLETES WITH HYPERTROPHIC CARDIOMYOPATHY, Circulation, 90(4), 1994, pp. 442-442
MUSCLE ENERGETICS DURING DYNAMIC EXERCISE IN HYPERTROPHIC CARDIOMYOPATHY
Authors: RYSCHON TW FOWLER MD ARAI AE WYSONG RE MCAREAVEY D EPSTEIN ND FANANAPAZIR L BALABAN RS
Citation: Tw. Ryschon et al., MUSCLE ENERGETICS DURING DYNAMIC EXERCISE IN HYPERTROPHIC CARDIOMYOPATHY, Circulation, 90(4), 1994, pp. 442-442
IDENTIFICATION OF BETA-MYOSIN HEAVY-CHAIN GENE-MUTATIONS IN 31 ATHLETES WITH HYPERTROPHIC CARDIOMYOPATHY
Authors: FANANAPAZIR L WINKLER JB SATORIUS C EPSTEIN ND
Citation: L. Fananapazir et al., IDENTIFICATION OF BETA-MYOSIN HEAVY-CHAIN GENE-MUTATIONS IN 31 ATHLETES WITH HYPERTROPHIC CARDIOMYOPATHY, Circulation, 90(4), 1994, pp. 442-442
MUSCLE ENERGETICS DURING DYNAMIC EXERCISE IN HYPERTROPHIC CARDIOMYOPATHY
Authors: RYSCHON TW FOWLER MD ARAI AE WYSONG RE MCAREAVEY D EPSTEIN ND FANANAPAZIR L BALABAN RS
Citation: Tw. Ryschon et al., MUSCLE ENERGETICS DURING DYNAMIC EXERCISE IN HYPERTROPHIC CARDIOMYOPATHY, Circulation, 90(4), 1994, pp. 442-442
DDD PACING MAY OBVIATE THE NEED FOR INVESTIGATION OF SYMPTOMS OF IMPAIRED CONSCIOUSNESS IN HYPERTROPHIC CARDIOMYOPATHY
Authors: MCAREAVEY D FANANAPAZIR L
Citation: D. Mcareavey et L. Fananapazir, DDD PACING MAY OBVIATE THE NEED FOR INVESTIGATION OF SYMPTOMS OF IMPAIRED CONSCIOUSNESS IN HYPERTROPHIC CARDIOMYOPATHY, Circulation, 90(4), 1994, pp. 443-443
DDD PACING MAY OBVIATE THE NEED FOR INVESTIGATION OF SYMPTOMS OF IMPAIRED CONSCIOUSNESS IN HYPERTROPHIC CARDIOMYOPATHY
Authors: MCAREAVEY D FANANAPAZIR L
Citation: D. Mcareavey et L. Fananapazir, DDD PACING MAY OBVIATE THE NEED FOR INVESTIGATION OF SYMPTOMS OF IMPAIRED CONSCIOUSNESS IN HYPERTROPHIC CARDIOMYOPATHY, Circulation, 90(4), 1994, pp. 443-443
RISK-EVALUATION, THERAPY, AND PROGNOSIS IN ATHLETES WITH HYPERTROPHICCARDIOMYOPATHY
Authors: FANANAPAZIR L EPSTEIN ND
Citation: L. Fananapazir et Nd. Epstein, RISK-EVALUATION, THERAPY, AND PROGNOSIS IN ATHLETES WITH HYPERTROPHICCARDIOMYOPATHY, Circulation, 90(4), 1994, pp. 443-443
RISK-EVALUATION, THERAPY, AND PROGNOSIS IN ATHLETES WITH HYPERTROPHICCARDIOMYOPATHY
Authors: FANANAPAZIR L EPSTEIN ND
Citation: L. Fananapazir et Nd. Epstein, RISK-EVALUATION, THERAPY, AND PROGNOSIS IN ATHLETES WITH HYPERTROPHICCARDIOMYOPATHY, Circulation, 90(4), 1994, pp. 443-443
GENOTYPE-PHENOTYPE CORRELATIONS IN HYPERTROPHIC CARDIOMYOPATHY - INSIGHTS PROVIDED BY COMPARISONS OF KINDREDS WITH DISTINCT AND IDENTICAL BETA-MYOSIN HEAVY-CHAIN GENE-MUTATIONS
Authors: FANANAPAZIR L EPSTEIN ND
Citation: L. Fananapazir et Nd. Epstein, GENOTYPE-PHENOTYPE CORRELATIONS IN HYPERTROPHIC CARDIOMYOPATHY - INSIGHTS PROVIDED BY COMPARISONS OF KINDREDS WITH DISTINCT AND IDENTICAL BETA-MYOSIN HEAVY-CHAIN GENE-MUTATIONS, Circulation, 89(1), 1994, pp. 22-32
ATPASE ACTIVITY AND ISOMETRIC FORCE GENERATED BY SINGLE SKELETAL MYOFIBERS IN HYPERTROPHIC CARDIOMYOPATHY ASSOCIATED WITH BETA-MYOSIN HEAVY-CHAIN GENE-MUTATIONS
Authors: CHAEN S HOROWITS R PODOLSKY RJ EPSTEIN ND FANANAPAZIR L
Citation: S. Chaen et al., ATPASE ACTIVITY AND ISOMETRIC FORCE GENERATED BY SINGLE SKELETAL MYOFIBERS IN HYPERTROPHIC CARDIOMYOPATHY ASSOCIATED WITH BETA-MYOSIN HEAVY-CHAIN GENE-MUTATIONS, Biophysical journal, 66(2), 1994, pp. 10000406-10000406
RESULTS OF PERMANENT DUAL-CHAMBER PACING IN SYMPTOMATIC NONOBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Authors: CANNON RO TRIPODI D DILSIZIAN V PANZA JA FANANAPAZIR L
Citation: Ro. Cannon et al., RESULTS OF PERMANENT DUAL-CHAMBER PACING IN SYMPTOMATIC NONOBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY, The American journal of cardiology, 73(8), 1994, pp. 571-576
MYOCARDIAL-ISCHEMIA DETECTED BY THALLIUM SCINTIGRAPHY IS FREQUENTLY RELATED TO CARDIAC-ARREST AND SYNCOPE IN YOUNG-PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
Authors: DILSIZIAN V BONOW RO EPSTEIN SE FANANAPAZIR L
Citation: V. Dilsizian et al., MYOCARDIAL-ISCHEMIA DETECTED BY THALLIUM SCINTIGRAPHY IS FREQUENTLY RELATED TO CARDIAC-ARREST AND SYNCOPE IN YOUNG-PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY, Journal of the American College of Cardiology, 22(3), 1993, pp. 796-804
MISSENSE MUTATIONS IN THE BETA-MYOSIN HEAVY-CHAIN GENE CAUSE CENTRAL CORE DISEASE IN HYPERTROPHIC CARDIOMYOPATHY
Authors: FANANAPAZIR L DALAKAS MC CYRAN F COHN G EPSTEIN ND
Citation: L. Fananapazir et al., MISSENSE MUTATIONS IN THE BETA-MYOSIN HEAVY-CHAIN GENE CAUSE CENTRAL CORE DISEASE IN HYPERTROPHIC CARDIOMYOPATHY, Proceedings of the National Academy of Sciences of the United Statesof America, 90(9), 1993, pp. 3993-3997
SKELETAL-MUSCLE EXPRESSION AND ABNORMAL FUNCTION OF BETA-MYOSIN IN HYPERTROPHIC CARDIOMYOPATHY
Authors: CUDA G FANANAPAZIR L ZHU WS SELLERS JR EPSTEIN ND
Citation: G. Cuda et al., SKELETAL-MUSCLE EXPRESSION AND ABNORMAL FUNCTION OF BETA-MYOSIN IN HYPERTROPHIC CARDIOMYOPATHY, The Journal of clinical investigation, 91(6), 1993, pp. 2861-2865
RATE-RESPONSIVE VENTRICULAR PACING IMPROVES DRUG-REFRACTORY SYMPTOMS AND HEMODYNAMIC INDEXES IN NONOBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY FOLLOWING RADIOFREQUENCY ABLATION OF ATRIOVENTRICULAR NODE FOR CHRONICATRIAL-FIBRILLATION
Authors: FANANAPAZIR L TRIPODI D MCAREAVEY D
Citation: L. Fananapazir et al., RATE-RESPONSIVE VENTRICULAR PACING IMPROVES DRUG-REFRACTORY SYMPTOMS AND HEMODYNAMIC INDEXES IN NONOBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY FOLLOWING RADIOFREQUENCY ABLATION OF ATRIOVENTRICULAR NODE FOR CHRONICATRIAL-FIBRILLATION, Circulation, 88(4), 1993, pp. 210-210
IN-VITRO MOTILITY ACTIVITY OF BETA-CARDIAC MYOSIN DEPENDS ON THE NATURE OF THE BETA-MYOSIN HEAVY-CHAIN GENE MUTATION IN HYPERTROPHIC CARDIOMYOPATHY
Authors: CUDA G SELLERS J EPSTEIN ND FANANAPAZIR L
Citation: G. Cuda et al., IN-VITRO MOTILITY ACTIVITY OF BETA-CARDIAC MYOSIN DEPENDS ON THE NATURE OF THE BETA-MYOSIN HEAVY-CHAIN GENE MUTATION IN HYPERTROPHIC CARDIOMYOPATHY, Circulation, 88(4), 1993, pp. 343-343
Risultati: 1-25 | 26-50 | 51-52